We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Hong Kong Firm Draws Warning for Testing, Labeling Deficiencies
Hong Kong Firm Draws Warning for Testing, Labeling Deficiencies
The FDA issued Nan San Pharmaceutical a warning letter for significant violations of CGMPs, including a failure to test product batches and inadequately labeling of product expiration dates.